Suppr超能文献

纳米技术赋能的神经退行性疾病治疗策略。

Nanotechnology-empowered therapeutics targeting neurodegenerative diseases.

机构信息

Skaggs Pharmaceutical Sciences Center, Department of Pharmacology & Toxicology, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, Arizona, USA.

BIO5 Institute, The University of Arizona, Tucson, Arizona, USA.

出版信息

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Sep-Oct;15(5):e1907. doi: 10.1002/wnan.1907. Epub 2023 May 30.

Abstract

Neurodegenerative diseases are posing pressing health issues due to the high prevalence among aging populations in the 21st century. They are evidenced by the progressive loss of neuronal function, often associated with neuronal necrosis and many related devastating complications. Nevertheless, effective therapeutical strategies to treat neurodegenerative diseases remain a tremendous challenge due to the multisystemic nature and limited drug delivery to the central nervous system. As a result, there is a pressing need to develop effective alternative therapeutics to manage the progression of neurodegenerative diseases. By utilizing the functional reconstructive materials and technologies with specific targeting ability at the nanoscale level, nanotechnology-empowered medicines can transform the therapeutic paradigms of neurodegenerative diseases with minimal systemic side effects. This review outlines the current applications and progresses of the nanotechnology-enabled drug delivery systems to enhance the therapeutic efficacy in treating neurodegenerative diseases. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Neurological Disease Therapeutic Approaches and Drug Discovery > Emerging Technologies.

摘要

神经退行性疾病是 21 世纪老龄化人口中发病率较高的紧迫健康问题。其表现为神经元功能的进行性丧失,常伴有神经元坏死和许多相关的严重并发症。然而,由于多系统性质和向中枢神经系统的药物输送有限,治疗神经退行性疾病的有效治疗策略仍然是一个巨大的挑战。因此,迫切需要开发有效的替代疗法来控制神经退行性疾病的进展。通过利用具有纳米级特定靶向能力的功能重建材料和技术,纳米技术增强的药物可以在最小的全身副作用下改变神经退行性疾病的治疗模式。这篇综述概述了纳米技术药物传递系统在增强治疗神经退行性疾病的疗效方面的应用和进展。本文属于以下类别: 治疗方法和药物发现 > 纳米医学治疗神经疾病 治疗方法和药物发现 > 新兴技术。

相似文献

1
Nanotechnology-empowered therapeutics targeting neurodegenerative diseases.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Sep-Oct;15(5):e1907. doi: 10.1002/wnan.1907. Epub 2023 May 30.
2
Nanotechnology-driven therapies for neurodegenerative diseases: a comprehensive review.
Ther Deliv. 2024;15(12):997-1024. doi: 10.1080/20415990.2024.2401307. Epub 2024 Sep 19.
3
Bioactive Compound-Fortified Nanocarriers in the Management of Neurodegenerative Disease: A Review.
Chem Biodivers. 2025 Jun;22(6):e202402018. doi: 10.1002/cbdv.202402018. Epub 2025 Feb 22.
4
Cell membrane-coated nanoparticles for neurodegenerative disorders management.
Int J Pharm. 2025 Aug 20;681:125875. doi: 10.1016/j.ijpharm.2025.125875. Epub 2025 Jun 20.
5
Emerging nanoparticle-based strategies to provide therapeutic benefits for stroke.
Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-24-01492.
6
Nitric Oxide Therapeutics: New Hopes for More Effective Tuberculosis Treatment Combine with Targeted and Controlled Nanotechnology.
Int J Nanomedicine. 2025 Jul 19;20:9195-9218. doi: 10.2147/IJN.S531255. eCollection 2025.
7
The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases.
Cell Prolif. 2025 Aug;58(8):e13804. doi: 10.1111/cpr.13804. Epub 2025 Feb 11.
8
Intranasal Therapeutics for Neurodegenerative Disorders: Overcoming the Blood-Brain Barrier with Smart Formulations and Devices.
Mol Pharm. 2025 Jul 7;22(7):3602-3620. doi: 10.1021/acs.molpharmaceut.5c00386. Epub 2025 Jun 23.
10
Inorganic Nanoparticles-based Drug Delivery Systems for Neurodegenerative Diseases Therapy.
Curr Pharm Des. 2025;31(25):1998-2024. doi: 10.2174/0113816128352935250116064725.

引用本文的文献

1
Nanomaterial-enabled drug delivery systems for circadian medicine: bridging direct rhythm modulation and chronotherapy.
RSC Adv. 2025 Sep 5;15(38):31981-32008. doi: 10.1039/d5ra04137f. eCollection 2025 Aug 29.
2
Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments - a state-of-the-art update.
Front Pharmacol. 2025 Jul 23;16:1630475. doi: 10.3389/fphar.2025.1630475. eCollection 2025.
5
(Nano)biotechnological approaches in the treatment of cervical cancer: integration of engineering and biology.
Front Immunol. 2024 Sep 13;15:1461894. doi: 10.3389/fimmu.2024.1461894. eCollection 2024.
8
Nanotechnology in the Diagnosis and Treatment of Antibiotic-Resistant Infections.
Antibiotics (Basel). 2024 Jan 25;13(2):121. doi: 10.3390/antibiotics13020121.

本文引用的文献

1
Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer Immunochemotherapy.
Mol Pharm. 2022 Dec 5;19(12):4665-4674. doi: 10.1021/acs.molpharmaceut.2c00701. Epub 2022 Nov 22.
2
Camptothesome elicits immunogenic cell death to boost colorectal cancer immune checkpoint blockade.
J Control Release. 2022 Sep;349:929-939. doi: 10.1016/j.jconrel.2022.07.042. Epub 2022 Aug 9.
3
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates.
Nat Biotechnol. 2022 Oct;40(10):1500-1508. doi: 10.1038/s41587-022-01334-x. Epub 2022 Jun 2.
4
Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders.
Materials (Basel). 2022 Jan 21;15(3):804. doi: 10.3390/ma15030804.
5
Nanotechnology in Improving the Treatment of Huntington's Disease: a Systematic Review.
Neurotox Res. 2022 Apr;40(2):636-645. doi: 10.1007/s12640-021-00468-1. Epub 2022 Jan 21.
7
Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNS.
Nat Biotechnol. 2021 Dec;39(12):1529-1536. doi: 10.1038/s41587-021-00972-x. Epub 2021 Aug 12.
9
An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's Disease.
N Engl J Med. 2021 Aug 26;385(9):856-857. doi: 10.1056/NEJMc2111960. Epub 2021 Jul 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验